Iovance Biotherapeutics Inc


Market Cap$2.36B

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Iovance Biotherapeutics IncIovance Biotherapeutics Inc00%---

Target Price by Analysts

194.9% upsideIovance Biotherapeutics Target Price DetailsTarget Price

Current Fair Value

97.5% downside

Overvalued by 97.5% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.36 Billion
Enterprise Value-
Dividend Yield$0.0 (0.0%)
Earnings per Share$0.0
Outstanding Shares279,832,722
Avg 30 Day Volume6,885,443


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio0.0
Price to Sales-
Price to Book Ratio-
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income-
Total Debt to Enterprise-
Debt to Equity-

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Iovance Biotherapeutics Inc

CEO: Maria Fardis